UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Pragmatic Approach to Identifying and Profiling Primary Care Clinicians and Primary Care Practices in the USA

Journal of general internal medicine : JGIM, 2024-08, Vol.39 (11), p.1962-1968

2024

Volltextzugriff (PDF)

Association Between Cost-Sharing and Buprenorphine Prescription Abandonment

Journal of general internal medicine : JGIM, 2024-09, Vol.39 (12), p.2160-2168

2024

Volltextzugriff (PDF)

Configuration and Delivery of Primary Care in Rural and Urban Settings

Journal of general internal medicine : JGIM, 2022-09, Vol.37 (12), p.3045-3053

2022

Volltextzugriff (PDF)

Population-Based Opioid Prescribing and Overdose Deaths in the USA: an Observational Study

Journal of general internal medicine : JGIM, 2023-02, Vol.38 (2), p.390-398

2023

Volltextzugriff (PDF)

Rapid Discontinuation of Chronic, High-Dose Opioid Treatment for Pain: Prevalence and Associated Factors

Journal of general internal medicine : JGIM, 2022-05, Vol.37 (7), p.1603-1609

2022

Volltextzugriff (PDF)

Racial-Ethnic Composition of Primary Care Practices and Comprehensive Primary Care Plus Initiative Participation

Journal of general internal medicine : JGIM, 2023-10, Vol.38 (13), p.2945-2952

2023

Volltextzugriff (PDF)

An Exploratory Analysis of Differential Prescribing of High-Risk Opioids by Insurance Type Among Patients Seen by the Same Clinician

Journal of general internal medicine : JGIM, 2023-05, Vol.38 (7), p.1681-1688

2023

Volltextzugriff (PDF)

Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US

Supportive care in cancer, 2024-06, Vol.32 (6), p.373, Article 373

2024

Volltextzugriff (PDF)

An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations

Journal of general internal medicine : JGIM, 2020-06, Vol.35 (6), p.1768-1775

2020

Volltextzugriff (PDF)

Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US

PharmacoEconomics, 2020-10, Vol.38 (10), p.1115-1121

2020

Volltextzugriff (PDF)

Does health technology assessment compromise access to pharmaceuticals?

The European journal of health economics, 2023-04, Vol.24 (3), p.437-451

2023

Volltextzugriff (PDF)

Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective

Applied health economics and health policy, 2024-09, Vol.22 (5), p.735-747

2024

Volltextzugriff (PDF)

The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK

The European journal of health economics, 2023-08, Vol.24 (6), p.895-907

2023

Volltextzugriff (PDF)

Does health technology assessment compromise access to pharmaceuticals?

The European journal of health economics, 2023-09, Vol.24 (7), p.1245-1248

2023

Volltextzugriff (PDF)

Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin

PharmacoEconomics, 2021-03, Vol.39 (3), p.317-330

2021

Volltextzugriff (PDF)

What About Offering a Financial Incentive Directly to Clinical Units to Encourage the Use of Biosimilars? Results of a Two-Year National Experiment in France

Applied health economics and health policy, 2023-09, Vol.21 (5), p.799-811

2023

Volltextzugriff (PDF)

Development of an Item Bank to Assess Patient-Reported Outcomes: Signs, Symptoms, and Impacts of COVID-19

The patient : patient-centered outcomes research, 2022-11, Vol.15 (6), p.703-713

2022

Volltextzugriff (PDF)

Does NICE influence the adoption and uptake of generics in the UK?

The European journal of health economics, 2021-03, Vol.22 (2), p.229-242

2021

Volltextzugriff (PDF)

High-Expenditure Disease in the EU-28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?

PharmacoEconomics - open, 2021-09, Vol.5 (3), p.385-396

2021

Volltextzugriff (PDF)

Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries

The European journal of health economics, 2020-06, Vol.21 (4), p.621-634

2020

Volltextzugriff (PDF)

A Relative Cost of Control Analysis of IDegLira versus Other Forms of Basal Insulin Intensification in Mexico

PharmacoEconomics - open, 2023-09, Vol.7 (5), p.841-849

2023

Volltextzugriff (PDF)

Estimation of the Incremental Cumulative Cost of HIV Compared with a Non-HIV Population

PharmacoEconomics - open, 2020-12, Vol.4 (4), p.687-696

2020

Volltextzugriff (PDF)

How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment

PharmacoEconomics, 2021-11, Vol.39 (11), p.1243-1269

2021

Volltextzugriff (PDF)

Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment

PharmacoEconomics, 2021-03, Vol.39 (3), p.275-285

2021

Volltextzugriff (PDF)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China

PharmacoEconomics, 2022-07, Vol.40 (7), p.715-724

2022

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Aktive Filter

ThemaHealth Care Sciences & Services

ThemaMedicine & Public Health

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(134)

Publikationsform

Artikel
(134)

Sprache

Englisch
(134)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(134)
Medicine
(134)
Health Policy & Services
(81)
Public Health
(72)
Economics
(68)
Pharmacoeconomics And Health Outcomes
(68)
Business & Economics
(65)
Social Sciences
(65)
Humans
(64)
Health Economics
(60)
Patients
(54)
Health Administration
(53)
Quality Of Life Research
(51)
General & Internal Medicine
(40)
Internal Medicine
(40)
Medicine, General & Internal
(40)
Original Research Article
(36)

12 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A Pragmatic Approach to Identifying and Profiling Primary Care Clinicians and Primary Care Practices in the USA

Association Between Cost-Sharing and Buprenorphine Prescription Abandonment

Configuration and Delivery of Primary Care in Rural and Urban Settings

Population-Based Opioid Prescribing and Overdose Deaths in the USA: an Observational Study

Rapid Discontinuation of Chronic, High-Dose Opioid Treatment for Pain: Prevalence and Associated Factors

Racial-Ethnic Composition of Primary Care Practices and Comprehensive Primary Care Plus Initiative Participation

An Exploratory Analysis of Differential Prescribing of High-Risk Opioids by Insurance Type Among Patients Seen by the Same Clinician

Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US

An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations

Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US

Does health technology assessment compromise access to pharmaceuticals?

Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective

The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK

Does health technology assessment compromise access to pharmaceuticals?

Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin

What About Offering a Financial Incentive Directly to Clinical Units to Encourage the Use of Biosimilars? Results of a Two-Year National Experiment in France

Development of an Item Bank to Assess Patient-Reported Outcomes: Signs, Symptoms, and Impacts of COVID-19

Does NICE influence the adoption and uptake of generics in the UK?

High-Expenditure Disease in the EU-28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?

Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries

A Relative Cost of Control Analysis of IDegLira versus Other Forms of Basal Insulin Intensification in Mexico

Estimation of the Incremental Cumulative Cost of HIV Compared with a Non-HIV Population

How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment

Common Problems, Common Data Model Solutions: Evidence Generation for Health Technology Assessment

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China

Aktive Filter

Suchergebnisse filtern